An Australian test subject in the Pfizer coronavirus vaccine trial claims participants suffered fevers and migraines after receiving the jab.
Scott Morrison ordered 10 million doses of the American vaccine and it could be rolled out across the country from next year if approved.
Pfizer reported a 90 per cent effectiveness rate in late-stage clinical trials, sparking hopes there may be a path out of the health crisis.
Stanley Wang, who lives in Los Angeles, told KIIS 101.1’s Jase and PJ that some of the trial participants had unpleasant side effects.
Pictured: A health worker injects a person during clinical trials for a coronavirus vaccine
He said these included fever and migraines, and another complained of having a reaction ‘similar to having a hangover’.
‘What’s interesting is they do keep you there after they inject you for about 30 minutes to make sure you’re okay and then they’ll send you home,’ he said.
Mr Wang said he went for his first injection on August 31 and did not experience any pain from the jab nor coronavirus symptoms.
’50 per cent of the trial participants got the placebo, while the other half got the actual vaccine. My injection didn’t hurt which leads me to believe that I have the placebo,’ he said.
Mr Wang said he volunteered for the trial because he wanted to help out in some way during the pandemic.
‘I wanted to do something so I looked up what I could do and I came across these trials that people were enrolling in to help with the efforts,’ he said.
Stanley Wang, who is based in LA, volunteered for Pfizer trial because he wanted to help out in some way during the pandemic
He is part of phase two and three of the Pfizer trial, which goes for 26 months.
Mr Wang explained the vaccine is stored at minus 70C and it takes about 15 minutes for medical workers to thaw it out.
He is paid US$120 per visit and required to attend either six or seven appointments, plus $5 a week by entering his symptoms in an app.
The first coronavirus jabs are expected to hit Australia in March.
Health Minister Greg Hunt believes Australia is on track to meet its timeline to start vaccinating people in the first quarter of next year.
Pfizer has reported a 90 per cent effectiveness rate in late-stage clinical trials, sparking hopes there may be a path out of the pandemic
He said health workers, the elderly and aged care staff would be the priority before making it progressively available to the general population.
‘We are on track to deliver vaccines to Australians, commencing in March of 2021. That is I think extremely important news,’ the minister said.
Prime Minister Scott Morrison will discuss the government’s vaccination policy with state and territory counterparts at Friday’s national cabinet meeting.
He said premiers and chief ministers would learn about actions needed to disseminate the vaccine.
The Pfizer vaccine uses genetic information to tell the body how to develop an immune response to coronavirus.
A health care worker injects a syringe during the phase 3 vaccine trial. The vaccine candidate is developed against coronavirus by the U.S. Pfizer and German BioNTech company
In September, an Oxford AstraZeneca volunteer revealed he suffered fever, chills, headache and fatigue 14 hours after having the anti-COVID jab.
The volunteer, who received his first shot in early May, told MailOnline the debilitating side effects lasted several days afterwards.
‘I woke up about 2am and I was freezing, but had a temperature above 39C,’ the man, who asked not to be named, said.
‘I felt incredibly weak and couldn’t really get up and move so my partner had to get me a paracetamol.
‘The temperature continued for about a day, and I just felt really weak and lethargic and couldn’t really do anything.’